Issue link: https://www.e-digitaleditions.com/i/1521797
Inhalation June 2024 21 Nasal product development and manufacturing services Bespak ® offers a fully integrated service for the devel- opment and manufacture of nasal drug delivery devices and drug-device combination products. In addition to our services for pressurized metered dose inhalers (pMDIs) and dry powder inhalers (DPIs), our capabil- ities encompass unit-dose and multi-dose nasal sprays. As part of a joint venture between Bespak and Med- spray, we also offer Resyca ® soft mist inhalers (SMIs) and nasal soft mist atomizers. Discover how we can provide support from concept to commercialization for your innovations in nasal drug delivery. Bespak UK: +44 1477 537112 enquiries@bespak.com www.bespak.com Improving the clinical realism of nebulizer testing e use of specific tidal breathing profiles for differ- ent patient groups enhances the clinical relevance of aerodynamic particle size distribution (APSD) assess- ments for nebulizers and soft mist inhalers (SMIs). e Breathing Simulator BRS 200i accurately repli- cates these profiles and can be used with an impactor within an NGI Cooler™. When paired with a Mixing Inlet, a steady flow rate can be maintained through the impactor, while a variable rate passes through the nebulizer/SMI under test. is approach enables more representative analysis as developers strive to bridge the gap between in vitro testing and clinical performance. For more information, please contact info@copleyscientific.co.uk. Copley Scientific UK: +44 1159 616229 info@copleyscientific.co.uk www.copleyscientific.com Respiratory drug product development software Fusion Process Development (FPD) for respiratory drug product R&D is the perfect companion mod- ule to Fusion Inhaler Testing (FIT) for QC. FPD has automated Design of Experiments (DoE) and data modeling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi-directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com Integrated nasal formulation, development and manufacturing Catalent provides comprehensive end-to-end solu- tions for formulation development, spray character- ization, process optimization and manufacturing for liquid and powder, unit-dose, bi-dose and multi-dose nasal products. With 30+ years of inhalation experi- ence, the Morrisville, NC, US facility offers focused and flexible customer service and clinical and commer- cial scale manufacturing, as well as extensive analytical services to support product development. As a trusted CDMO with a strong track record in successfully developing and commercializing nasal drug products to support both US and global product needs, partner with Catalent to bring your nasal therapy from con- cept to market and ultimately to patients. Catalent Inhalation US: +1 888 SOLUTION (765-8846) solutions@catalent.com www.catalent.com